➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Express Scripts
Johnson and Johnson
McKinsey
Merck

Last Updated: November 30, 2020

DrugPatentWatch Database Preview

Claims for Patent: 4,486,403

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 4,486,403
Title: Composition for and treatment of teeth
Abstract:The invention relates to compositions and treatments for inhibiting or eliminating the formation of dental caries. The composition comprises a dental carie inhibiting effective amount of a compound containing a thiol group or a disulfide group which compound acts as a collagenase inhibitor and a pharmaceutically acceptable carrier adapted to be applied to and maintained in contact with the teeth. In accordance with the invention this composition is applied to the teeth, the collagenase inhibitor acting to inhibit or even eliminate the formation of dental caries.
Inventor(s): Mechanic; Gerald (Chapel Hill, NC), Binderman; Itzhak (Tel-Aviv, IL)
Assignee:
Application Number:06/450,926
Patent Claims:1. Method for the inhibition or elimination of the formation of dental caries, which comprises the steps of

applying to the teeth to be treated, a collagenase-inhibiting effective amount essentially of cysteine in free form or in the form of a pharmaceutically acceptable salt or complex, and

allowing said collagenase-inhibiting effective amount of cysteine to contact the teeth for a time sufficient to act on the teeth and inhibit the action of collagenase, thereby preventing the formation of dental caries.

Summary for Patent:   Start Trial

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel64700Jan 01, 1982

Details for Patent 4,486,403

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Smith And Nephew SANTYL collagenase OINTMENT;TOPICAL 101995 001 1965-06-04   Start Trial 2002-01-01 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKinsey
Dow
AstraZeneca
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.